Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy
A recent study from Spain showed that the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can change the overall structure and diversity of the nasopharyngeal microbiota in pregnant women – which persists even weeks after clinical infection. // 3.2.2022
Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2
Nature Communications - As pregnant women are considered vulnerable to SARSCoV-2 infection, it is important to investigate the actual risks involved.
”The authors noted that the potential long-term effects of this inflammatory process on infants requires further study.”
// 18.1.2022
Vastasyntyneitä kuoli oudon paljon Skotlannissa – Tutkimus paljasti: äidin koronainfektio raskauden lopulla lisää roimasti lapsen riskiä kuolla alle 4-viikkoisena
Skottitutkimus perkasi 144000 pandemian aikaista raskautta ja niihin liittyviä vastasyntyneiden kuolintapauksia. // 17.1.2022
Unvaccinated pregnant women more likely to experience severe covid symptoms and newborn deaths, study says
The results of the Scottish study bolster calls to vaccinate more pregnant people to protect both parents and babies during the pandemic, experts say. // 14.1.2022
SARS-CoV-2 placentitis associated with B.1.617.2 (Delta) variant and fetal distress or demise
Abstract. There is limited information on the specific impact of maternal infection with the SARS-CoV-2 B.1.617.2 (Delta) variant on pregnancy outcomes. // 13.1.2022
The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study
// 13.1.2022
”Women who got COVID while pregnant in five Western U.S. states were more likely to have premature births, low birth weights, and stillbirths, even when the COVID cases are mild.”
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
Nature Medicine - Findings from the COVID-19 in Pregnancy in Scotland (COPS) study reveals low levels of vaccination uptake by pregnant women compared to women in the general population and that... // 13.1.2022
Vaccinated mothers transfer SARS-CoV-2 antibodies to their breastfed infants
Women vaccinated against COVID-19 transfer SARS-CoV-2 antibodies to their breastfed infants, potentially giving their babies passive immunity against the coronavirus, according to University of Massachusetts Amherst research. // 7.1.2022
Morbidity and Mortality Weekly Report (MMWR) Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021
This report describes how COVID-19 vaccination during pregnancy was not associated with preterm or small-for-gestational-age at birth compared with unvaccinated pregnant women. // 4.1.2022
COVID-19 mRNA vaccines offer protection against Omicron variant in pregnancy
A new study provides insights into the persistence of extra-neutralizing properties of mRNA vaccine-induced antibodies resulting in protection against the Omicron variant of SARS-CoV-2. // 5.1.2022
Altered cytokine profiles of COVID-19-infected mother-infant dyads may impair long-term infant health
New study findings suggest that both SARS-CoV-2-infected mothers and their fetuses have increased levels of inflammatory cytokines throughout gestation, which may potentially impact fetus health in the long term. // 31.12.2021
SARS-CoV-2 in Pregnant Women: Consequences of Vertical Transmission
Beginning in December 2019, multiple cases of pneumonia were reported in the city of Wuhan, China, but further scans of the respiratory tract and the genetic sequencing of infected individuals revealed the presence of a novel coronavirus, later designated as SARS-CoV-2 (Gao et al., 2020); the subsequent disease, now widely known as COVID-19. // 9.9.2021
SARS-CoV-2 infection and immunity in pregnancy and fetal development
A review conducted by a team of researchers from the Icahn School of Medicine at Mount Sinai, the University of Colorado, and Active Motif, Incorporated compiles information on SARS-CoV-2 virology, in utero transmission from infected pregnant mothers to fetuses, new findings on possible methods of SARS-CoV-2 cellular trafficking through exosomes, and the transcriptomic effects of SARS-CoV-2 infection, in order to inform future studies aimed at a better understanding of COVID-19 and the development of therapeutic solutions against SARS-CoV-2. // 30.12.2021
Raskaus lisää riskiä sairastua vakavaan tautiin, ja sairaaloissa on nähty hankalia tilanteita. Rokotteen ottamista suositellaan, sillä se suojaa vaikealta taudilta ja tehohoitoon joutumiselta. // 31.12.2021
Sairaalassa on nähty vaikeita tilanteita raskaana olevilla – TAYSin ylilääkäri: koronainfektio on hengenvaarallinen raskaana olevalle rokottamattomalle
Laajan näytön mukaan koronarokote on turvallinen sekä äidille, että sikiölle. Rokottamattoman raskaus sen sijaan ei. // 21.12.2021
Infektiolääkäri raskaana oleville: ”Olemme nähneet tosi vakavia tapauksia”
Korona leviää tällä hetkellä niin aktiivisesti, että se tulee saavuttamaan myös pienimpien kuntien asukkaat, jotka tähän asti ovat olleet ehkä... // 21.12.2021
Pandemic poses short- and long-term risks to babies, especially boys
The pandemic has created a hostile environment for pregnant people and their babies. Stress levels among expectant mothers have soared. Pregnant women with covid are five times as likely as uninfected pregnant people to require intensive care and 22 times as likely to die. Infected moms are four times as likely to have a stillborn child. // 21.12.2021
Maternal and neonatal cord-blood antibody profile in response to SARS-CoV-2
The goal of the current research was to determine the profile and specificity of maternal serum and neonatal cord blood antibody responses to SARS-CoV-2 virus exposure in mothers. // 10.12.2021
Experts urge pregnant women to get COVID-19 vaccine following new UK safety data
The country's top doctors and medical experts are urging pregnant women to get their COVID-19 vaccine as soon as possible, as new data published by the UK Health Security Agency (UKHSA) today [November Thursday 25] provides further evidence that the vaccines are safe for this group.
Antibody persistence in infants after maternal COVID-19 vaccination
New research finds COVID-19 vaccination during pregnancy results in significantly greater antibody persistence in the infants compared to natural infection of the mothers during pregnancy. // 24.11.2021
Odottavalla äidillä kaksinkertainen riski joutua sairaalahoitoon koronan takia – "Raskaus ja korona eivät ole todellakaan hyvä yhdistelmä"
Raskaana olevilla naisilla riski pahaan koronatartuntaan on olennaisesti korkeampi. Rokotetta suositellaan missä vaiheessa tahansa raskausaikaa. // 22.11.2021
Morbidity and Mortality Weekly Report (MMWR) Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization — United States, March 2020–September 2021
Implementing evidence-based COVID-19 prevention strategies, including vaccination before or during pregnancy, is critical to reduce the impact of COVID-19 on stillbirths // 20.11.2021